XV Jornadas de Engenharia Biomédica

Saudações Biomédicas!
A 4ª confirmação do dia está aqui! É com muito prazer que anunciamos a presença da terceira empresa oradora, BIOFABICS, apresentada por Pedro Costa.
​ Dr. Pedro Costa is a researcher, inventor, educator and entrepreneur. He is the founder, CEO and CTO of the company BIOFABICS, which is specialized in the creation of 3D biotissue analogues. Before that, he was the coordinator of the world’s first MSc Programme in Biofabrication at Utrecht University, manager of the Utrecht Biofabrication Facility and postdoctoral researcher at the University Medical Center Utrecht (Netherlands). Dr. Costa can be described as a biologist by training and engineer/maker by heart, given his undergraduate studies in applied biology followed by a PhD in biomedical engineering where he specialized in the application/combination of highly automated tools such as additive manufacturing (3D bioprinting) and bioreactor technologies in the field of tissue engineering and regenerative medicine. He has previously worked in both academic and industrial environments in places such as Portugal (University of Minho), Belgium (Materialise NV), Australia (Queensland University of Technology) and Germany (Technical University of Munich). Dr. Costa has also received several awards for his work, among them the 2014 Translational Award (European Society for Biomaterials) and the 2016 Young Investigator Award (2nd place) (International Society for Biofabrication). In 2018 he was also awarded with a Marie Sklodowska-Curie Individual Fellowship from the European Union’s Horizon 2020 research and innovation programme. Biofabics is an R&D company specialized in the generation of 3D biotissue analogues. It provides next-generation solutions for studying, mimicking, repairing and replacing living tissues and organs. In particular, Biofabics develops: truly 3D customizable organ-on-chip devices for drug discovery and personalized diagnostic/treatment; body-like environments for study of cells and tissues in in vivo-like states; tailor-made implants and bioreactors for research and implantation. Biofabics provides R&D services to companies and labs around the world who are looking to employ novel, more accurate, and more reliable tissue/organ models in their own research activities. Biofabics draws its expertise and know-how from its team’s decades of research and innovation activities at the intersection of fields and technologies such as biofabrication, 3D (bio)printing, microfluidics, organs-on-chips & bioreactors, tissue engineering & regenerative medicine, biomaterials, cell & tissue biology, mechatronics & software development.
Biofabics intends to democratise the access to organ-on-chip and biofabrication technologies by empowering researchers with its know-how, its advanced manufacturing capabilities and its user-friendly software tools. In this sense, it has recently launched the BIOFABICS TOOLBOX (www.biofabics-toolbox.com), which acts as an online database of design tools and where researchers are able to easily design and request their own highly customized devices through a very straightforward online interface. The BIOFABICS TOOLBOX was developed in the scope of project 3DPRINT-VASCU-CHIP. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 798014. Gostarias de conhecer um pouco mais desta área? Esperamos por ti dia 5